Mineralys Therapeutics, Inc.
MLYS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$178 | -$72 | -$30 | -$19 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $11 | $5 | $0 | $0 |
| Change in WC | $10 | -$7 | $1 | $4 |
| Other Non-Cash | -$9 | -$7 | -$1 | $1 |
| Operating Cash Flow | -$166 | -$81 | -$29 | -$15 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$373 | -$348 | -$72 | $0 |
| Inv. Sales/Matur. | $489 | $188 | $50 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $115 | -$160 | -$22 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $116 | $203 | $0 | $0 |
| Stock Repurch. | $0 | $0 | -$2 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $130 | $24 |
| Financing Cash Flow | $116 | $203 | $128 | $24 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $65 | -$38 | $77 | $9 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $49 | $88 | $11 | $1 |
| End Cash | $114 | $49 | $88 | $11 |
| Free Cash Flow | -$166 | -$81 | -$29 | -$15 |